The effects of SGLT-2 inhibitors on echocardiographic indices and antioxidative properties in patients with heart failure with reduced ejection fraction and diabetes mellitus.
SGLT-2 抑制劑對於心臟射出分數降低及糖尿病患者的超聲心動圖指標和抗氧化特性的影響。
Eur Rev Med Pharmacol Sci 2024-09-04
Left Ventricular Systolic Function After 3 Months of SGLT2 Inhibitor Therapy in Heart Failure Patients with Reduced Ejection Fraction.
心力衰竭患者使用 SGLT2 抑制劑治療後3個月的左心室收縮功能。
J Cardiovasc Transl Res 2023-11-20
Dapagliflozin Improved Cardiac Function and Structure in Diabetic Patients with Preserved Ejection Fraction: Results of a Single Centre, Observational Prospective Study.
Dapagliflozin 改善糖尿病患者保留射血分數的心臟功能和結構:單中心觀察性前瞻性研究結果。
J Clin Med 2023-11-03
Impact of sodium glucose co-transporter-2 inhibitors on left atrial functions in patients with type-2 diabetes and heart failure with mildly reduced ejection fraction.
SGLT-2 抑制劑對2型糖尿病合併心臟衰竭且左心室射血分數輕度降低患者的左心房功能影響。
Int J Cardiol Heart Vasc 2024-01-09
The effect of sodium-glucose cotransporter 2 inhibitors on left cardiac remodelling in heart failure with reduced ejection fraction: Systematic review and meta-analysis.
SGLT-2 抑制劑對收縮功能減弱心衰左心臟重塑的影響:系統性回顧與荟萃分析。
Eur J Heart Fail 2024-03-27
Effect of empagliflozin on left ventricular volumes in type 2 diabetes or prediabetes heart failure patients with reduced ejection fraction.
empagliflozin對2型糖尿病或糖尿病前期心臟衰竭患者左心室容積的影響。
Acta Cardiol 2024-03-21
Improvements of myocardial strain and work in diabetes patients with normal ejection fraction after empagliflozin treatment.
糖尿病患者在 empagliflozin 治療後心臟肌肉應變和功率的改善。
J Diabetes Investig 2024-03-27
Impact of SGLT2 inhibition on markers of reverse cardiac remodelling in heart failure: Systematic review and meta-analysis.
SGLT2 抑制對心衰竭中逆向心臟重塑標記的影響:系統性回顧與統合分析。
ESC Heart Fail 2024-07-26
Effects of 6-month administration of tofogliflozin on cardiac function in elderly patients with heart failure with preserved ejection fraction: A retrospective study of a patient cohort.
托福格列淨對於心臟功能的六個月施用效果:針對老年心臟衰竭且射血分數保留的患者群體的回顧性研究。
Medicine (Baltimore) 2024-08-09
Effects of SGLT2-Inhibitors on Comprehensive Geriatric Assessment, Biomarkers of Oxidative Stress, and Platelet Activation in Elderly Diabetic Patients with Heart Failure with Preserved Ejection Fraction.
SGLT2 抑制劑對心臟功能保留的老年糖尿病患者的綜合老年評估、氧化壓力生物標記及血小板活化的影響。
Int J Mol Sci 2024-08-29